FMP
Sep 22, 2022 7:29 PM - Davit Kirakosyan
The Chemours Company (NYSE:CC) shares were trading more than 4% lower Thursday afternoon following the company’s updated guidance announcement. Full 2022-year EBITDA guidance was lowered to a range of $1.40-$1.45 billion, down from the previous range of $1.475-$1.575 billion. Furthermore, the company revised its free cash flow guidance to around $575 million, down from $600 million.
Following the update, the analysts at RBC Capital lowered their estimates due to weakness in the company’s TT segment. 2022 and 2023 EBITDA estimates moved to $1.4 billion and $1.25 billion, respectively, down from $1.575 billion in both years.
According to the analysts, higher natural gas and other cost increases due to the Russia/Ukraine conflict have resulted in weak demand in TT, while the APM and TSS segments remain stable, mostly in North America.
Sep 11, 2023 1:38 PM - Rajnish Katharotiya
Price to Earnings is one of the key metrics use to value companies using multiples. The P/E ratio and other multiples are relative valuation metrics and they cannot be looked at in isolation. One of the problems with the P/E metric is the fact that if we are in the peak of a business cycle, earni...
Sep 11, 2023 1:49 PM - Rajnish Katharotiya
Price-to-Earnings ratio is a relative valuation tool. It is used by investors to find great companies at low prices. In this post, we will build a Python script to calculate Price Earnings Ratio for comparable companies. Photo by Skitterphoto on Pexels Price Earnings Ratio and Comparable Compa...
Oct 17, 2023 3:09 PM - Davit Kirakosyan
Shares of VMware (NYSE:VMW) witnessed a sharp drop of 12% intra-day today due to rising concerns about China's review of the company's significant sale deal to Broadcom. Consequently, Broadcom's shares also saw a dip of around 4%. Even though there aren’t any apparent problems with the proposed solu...